Literature DB >> 26405759

HPLC Separation of Vitamin E and Its Oxidation Products and Effects of Oxidized Tocotrienols on the Viability of MCF-7 Breast Cancer Cells in Vitro.

Astrid M Drotleff1, Anne Büsing1, Ina Willenberg1, Michael T Empl1, Pablo Steinberg1, Waldemar Ternes1.   

Abstract

Tocotrienols, a vitamin E subgroup, exert potent anticancer effects, but easily degrade due to oxidation. Eight vitamin E reference compounds, α-, β-, γ-, or δ-tocopherols or -tocotrienols, were thermally oxidized in n-hexane. The corresponding predominantly dimeric oxidation products were separated from the parent compounds by diol-modified normal-phase HPLC-UV and characterized by mass spectroscopy. The composition of test compounds, that is, α-tocotrienol, γ-tocotrienol, or palm tocotrienol-rich fraction (TRF), before and after thermal oxidation was determined by HPLC-DAD, and MCF-7 cells were treated with both nonoxidized and oxidized test compounds for 72 h. Whereas all nonoxidized test compounds (0-100 μM) led to dose-dependent decreases in cell viability, equimolar oxidized α-tocotrienol had a weaker effect, and oxidized TRF had no such effect. However, the IC50 value of oxidized γ-tocotrienol was lower (85 μM) than that of nonoxidized γ-tocotrienol (134 μM), thereby suggesting that γ-tocotrienol oxidation products are able to reduce tumor cell viability in vitro.

Entities:  

Keywords:  HPLC-DAD; alamarBlue assay; dimeric oxidation products; human MCF-7 breast cancer cells; tocopherols; tocotrienols; viability; vitamin E

Mesh:

Substances:

Year:  2015        PMID: 26405759     DOI: 10.1021/acs.jafc.5b04388

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  2 in total

Review 1.  Tocopherols and Tocotrienols in Common and Emerging Dietary Sources: Occurrence, Applications, and Health Benefits.

Authors:  Fereidoon Shahidi; Adriano Costa de Camargo
Journal:  Int J Mol Sci       Date:  2016-10-20       Impact factor: 5.923

2.  Down-regulation of C35 decreased the cell viability and migration of breast ductal carcinoma cells.

Authors:  Wen Che; Yun Bao; Feng Tang
Journal:  PLoS One       Date:  2017-08-31       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.